Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.581EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.301EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.308EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.210EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.325EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.590EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.116EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.496EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.49 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.367EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.385EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.244EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.7.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.10.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KG.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used